Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis

Publication Date

8-6-2022

Presented At:

IASLC 2022 World Conference on Lung Cancer

Content Type

Poster

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS